Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Other financing activities (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Other financing activities for 3 consecutive years, with $134000.0 as the latest value for Q2 2025.

  • Quarterly Other financing activities fell 86.6% to $134000.0 in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $199000.0 through Dec 2025, down 87.82% year-over-year, with the annual reading at $199000.0 for FY2025, 76.67% down from the prior year.
  • Other financing activities for Q2 2025 was $134000.0 at Mereo BioPharma, up from $65000.0 in the prior quarter.
  • The five-year high for Other financing activities was $1.0 million in Q2 2024, with the low at $40000.0 in Q4 2024.
  • Average Other financing activities over 3 years is $385166.7, with a median of $306000.0 recorded in 2023.
  • The sharpest move saw Other financing activities crashed 91.63% in 2024, then plummeted 86.6% in 2025.
  • Over 3 years, Other financing activities stood at $478000.0 in 2023, then plummeted by 91.63% to $40000.0 in 2024, then soared by 235.0% to $134000.0 in 2025.
  • According to Business Quant data, Other financing activities over the past three periods came in at $134000.0, $65000.0, and $40000.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.